Orchid Cellmark UK Forensic Contracts Extended | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark today announced the two-year extension of contracts previously awarded under the North West/South West and Wales regional forensic tender process in the UK.

The contracts, originally awarded in April 2008, were set to expire in 2011 and have been extended to 2013. In total, the contracts have a value of about $10 million, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.